Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes

Circulation Research

Volumn 78, Issue 1, 1996, Pages 91-101

  Kojda, Georg ^a   Kottenberg, Karin ^a   Nix, Petra ^a   Schlüter, Klaus Dieter ^b   Piper, Hans Michael ^b   Noack, Eike ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

cardiomyocytes; contractility; heart muscle; nitric oxide; organic nitrates

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; ISOPRENALINE; N ACETYL S NITROSOPENICILLAMINE; NITRATE; PENTAERYTHRITYL TETRANITRATE;

ANIMAL CELL; ARTICLE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME REGULATION; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE WALL; MALE; NONHUMAN; PHOSPHATE METABOLISM; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0030051387     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.1.91     Document Type: Article

References (49)

1. Ahlner J, Andersson RGG, Torfgård K, Axelsson KL. Organic nitrate esters: clinical use and mechanisms of actions. Pharmacol Rev. 1991;43:351-423.
2. Ignarro LJ, Lipton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218:739-749.
3. Noack E, Feelisch M. Molecular mechanism of nitrovasodilator bioactivation. In: Drexler H, Zeiher AM, Bassenge E, Just H, eds. Endothelial Mechanism of Vasomotor Control. Darmstadt, FRG: Steinkopff Verlag; 1991:37-50.
4. Noack N, Kojda G. Pentaerythrityltetranitrat Gesichertes und Neues zur Pharmakologie eines Langzeitnitrates. Darmstadt, FRG: Steinkopff Verlag; 1993.
5. Chung SJ, Fung HL. Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells. J Pharmacol Exp Ther. 1990;253:614-619.
6. Salvemini D, Mollace V, Pistelli A, Anggard E, Vane J. Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherischia coli lipopolysaccharide. Proc Natl Acad Sci U S A. 1992;89:982-986.
7. Morley D, Maragos CM, Zhang XY, Boignon M, Wink DA, Keefer LK. Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators. J Cardiovasc Pharmacol. 1993;21:6070-6076.
8. Förstermann U, Pollock JS, Schmidt HHHW, Heller M, Murad F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci U S A. 1991;88:1788-1792.
9. Salvemini D, Pistelle A, Mollace V, Änggard E, Vane J. The metabolism of glyceryl trinitrate to nitric oxide in the macrophage cell line J774 and its induction by Escherichia coli lipopolysaccharide. Biochem Pharmacol. 1992;44:17-24.
10. Nawrath H. Does cyclic GMP mediate the negative inotropic effect of acetylcholine in the heart? Nature. 1977;267:72-74.
11. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci U S A. 1991;88:1197-1201.
12. Krause EG, Halle W, Wollenberger A. Effect of dibutyryl cyclic GMP on cultured beating rat heart cells. Adv Cyclic Nucleotide Res. 1972;1:301-305.
13. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 1993;265(Heart Circ Physiol 34):H176-H182.
14. Ishibashi T, Hamaguchi M, Kato K, Kawada T, Otha H, Sasage H, Imai S. Relationship between myoglobin contents and increases in cyclic GMP produced by glyceryl trinitrate and nitric oxide in rabbit aorta, right atrium and papillary muscle. Naunyn Schmiedebergs Arch Pharmacol. 1993;347:553-561.
15. 2+ current in guinea-pig ventricular cells. J Physiol (Lond). 1991;443:387-404.
16. Brixius K, Kojda G, Noack E. Influence of pentaerythrityltetranitrate and isosorbidemononitrate on cardiac actions of norepinephrine. Naunyn Schmiedebergs Arch Pharmacol. 1994;349(suppl):R26. Abstract.
17. Piper HM, Probst I, Schwartz P. Culturing of calcium stable adult cardiac myocytes. J Mol Cell Cardiol. 1982;14:397-412.
18. Piper HM, Volz A, Schwartz P. Adult ventricular rat heart muscle cells. In: Piper HM, ed. Cell Culture Techniques in Heart and Vessel Research. Heidelberg, FRG: Springer Verlag; 1990:36-60.
19. Piper HM, Jacobson SL, Schwartz P. Determinants of cardiomyocyte development in long-term primary culture. J Mol Cell Cardiol. 1988;20:825-835.
20. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
21. Kojda G, Noack E. Nitric oxide liberating, soluble guanylate cyclase stimulating and vasorelaxing properties of the new nitrate-compound SPM 3672. J Cardiovasc Pharmacol. 1993;22:103-111.
22. Piper HM, Millar BC, McDermott JR. The negative inotropic effect of NPY on the ventricular cardiomyocyte. Naunyn Schmiedebergs Arch Pharmacol. 1989;340:333-337.
23. Field L, Dilts RV, Ravichandran R, Lenhert G, Carnahan GE. An unusual stable thionitrite from N-acetyl-D,L-penicillamin; x-ray crystal and molecular structure of 2-(acetylamino)-2-carboxy-1,1-dimethylethyl thionitrite. J C S Chem Comm. 1978;1157:249-250.
24. Maragos CM, Morely D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Isaac L, Hrabie JA, Keefer LK. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide: vasorelaxant effects. J Med Chem. 1991;34: 3242-3247.
25. ++-dependent constitutive nitric oxide synthase is not involved in the cGMP-increasing effects of carbachol in ventricular myocytes. J Pharmacol Exp Ther. 1993;266:919-925.
26. Trautwein W, Trube G. Negative inotropic effect of cyclic GMP in cardiac fiber fragments. Pflugers Arch. 1976;366:293-295.
27. Singh J, Flitney FW. Inotropic responses of the frog ventricle to dibutyryl cyclic AMP and 8-bromo-cyclic GMP and related changes in endogenous cyclic nucleotide levels. Biochem Pharmacol. 1981; 30:1475-1481.
28. 2+ current in single heart cells. Nature. 1986;323: 273-275.
29. Levi RC, Alloatti G, Fischmeister R. Cyclic GMP regulates the Ca-channel current in guinea pig ventricular myocytes. Pflugers Arch. 1989;413:685-687.
30. Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Sato A, Kaneko M. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide dependent protein kinases. Biochem Biophys Res Commun. 1987;142:436-440.
31. Parker-Bothello LH, Rothermel JD, Coombs RV, Jastorff B. cAMP analog antagonists of cAMP action. Methods Enzymol. 1988;159: 159-172.
32. Weißhaar RE, Kobylarz-Singer DC, Kaplan HR. Subclasses of cyclic AMP phosphodiesterase in cardiac muscle. J Mol Cell Cardiol. 1987;19:1025-1036.
33. Weißhaar RE, Kobylarz-Singer DC, Steffen RP, Kaplan HR. Subclasses of cyclic AMP-spccific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility. Circ Res. 1987;61:539-547.
34. Bowen R, Haslam RJ. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood: role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1. J Cardiovasc Pharmacol. 1991;17:424-433.
35. 2+ current. J Biol Chem. 1993;268: 26286-26295.
36. Wahler GM, Dollinger SJ. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am J Physiol. 1995;268(Cell Physiol 37):C45-C54.
37. 2+ in intact cardiac myocytes. Circ Res. 1994;74;970-978.
38. Butt E, Nolte C, Schulz S, Beltman J, Beavo JA, Jastorff B, Walter U. Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP. Biochem Pharmacol. 1992;43:2591-2600.
39. Diamond J, Ten Eick RE, Trapani AJ. Are increases in cyclic GMP levels responsible for the negative inotropic effects of acetylcholine in the heart? Biochem Biophys Res Commun. 1977;79:912-918.
40. Sys SU, Mohan P, Brutsaert DL. Positive inotropic effect of sodium nitroprusside in isolated cardiac muscle without endothelium. Circulation. 1993;88(suppl I):I-276. Abstract.
41. Grocott-Mason RM, Fort S, Lewis MJ, Shah AJ. Myocardial relaxant effect of exogenous nitric oxide in the isolated ejecting heart. Am J Physiol. 1994;266(Heart Circ Physiol 35):H1699-H1705.
42. Paulus WJ, Vantrimpont PJ, Shah AJ. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Circulation. 1994;89:2070-2078.
43. G-Methyl-L-arginine decreases contractility, cGMP and cAMP in isoproterenol-stimulated rat hearts in vitro. Eur J Pharmacol. 1992; 223:1-7.
44. Klabunde RE, Ritger RC, Helgren MC. Cardiovascular actions of inhibitors of endothelium derived relaxing factor (nitric oxide) formation/release in anaesthetized dogs. Eur J Pharmucol. 1991;223: 1-7.
45. G-methyl-L-arginine in chronically instrumented dogs. J Appl Phvsiol. 1994;77:471-475.
46. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol. 1992;105:575-580.
47. Balligand JL, Kelly RA, Marsden PA, Schmith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A. 1993;90:347-351.
48. De Belder AJ, Radomski MW, Why HJF, Richardson PJ, Bucknall CA, Salas E, Martin JF, Moncada S. Nitric oxide synthase activities in human myocardium. Lancet. 1993;341:84-85.
49. Schmidt HHHW, Walter U. NO at work. Cell. 1994;78:919-925.